Practical clinical evaluation of stents

Journal of Interventional Cardiology

Volumn 11, Issue 5 II, 1998, Pages

  Nguyen, Thach ^a   Dave, Vijay ^a   Jia, Sanqing ^b   Fang, Chen ^b   Wang, Lefeng ^b   Zhang, Chen ^c   Nguyen, James ^d   Fearnot, Neal ^e   Saito, Shigeru ^f  

^a St Mary Medical Center   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c AUBURN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Med Institute Inc Lafayette   (United States)

^f SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; GOLD; HEPARIN; PACLITAXEL; SILICONE;

CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; HEART CATHETER; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

EID: 0031742710     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1998.tb00198.x     Document Type: Conference Paper

References (43)

1. Hehrlein C, Zimmermann M, Metz J, et al. Influence of surface texture and charge on the biocompatibility of endovascular stents. Coronary Artery Disease 1995;6:581-586.
2. De Scheerder IK, Sohier J, Wang K, et al. Metallic surface treatment using electrochemical polishing decreases thrombogenicity and neointimal hyperplasia after coronary stent implantation in a porcine model. (Abstract) Eur Heart J 1997;18(Suppl.):153.
3. Moussa I, Di Mario C, Di Francesco L, et al. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol 1996;78(3A): 13-17.
4. Rogers C, Karnowsky MJ, Edelman ER. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 1993;88:1215-1221.
5. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91: 2295-3001.
6. Barth KH, Virmani R, Froelh J, et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 1996;93:2161-2169.
7. Strauss BH, Chisholm RJ, Keeley FW, et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-658.
8. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. JACC 1992;19:267-274.
9. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-2821.
10. Gordon PC, Gibson CM, Cohen DJ, et al. Mechanisms of restenosis and redilatation within coronary stents-quantitative angiographic assessment. JACC 1993;21:1166-1174.
11. Mintz GS, Pichard AD, Kent KM, et al. Endovascular stents reduce restenosis by eliminating geometric arterial remodeling: a serial intravascular ultrasound study. (Abstract) JACC 1995; 25:36A.
12. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
13. Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. JACC 1996;28:1134-1139.
14. Karas SP, Gravanis MB, Santoian EC, et al. Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis. JACC 1992;20:467-474.
15. Hanke H, Kamenz J, Hassenstein S, et al. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 1995;16:785-793.
16. Schatz RA, Firth BG. The Palmaz-Schatz coronary stent: New developments. In Serruys PW, ed. Handbook of Coronary Stents. London: Martin Dunitz, 1997, pp. 21-32.
17. Cannon A, Roubin GS. Gianturco-Roubin stent to treat vessel closure complicating angioplasty. In Roubin GS, Califf RM, O'Neill MW, Phillips HR, Stack RS, eds. Interventional Cardiovascular Medicine Principles and Practice. New York: Churchill Livingstone, 1994, pp. 865-886.
18. Roubin GS, Yadav JS. The Gianturco-Roubin II (GRII) stent. In Serruys PW, ed. Handbook of Coronary Stents. London: Martin Dunitz, 1997, pp. 15-20.
19. Rozenman Y, Lotan C, Mosseri M, et al. Experience with the AVE Micro stent in native coronary arteries. Am J Cardiol 1996;78:685-687.
20. Carrozza JP Jr, Hermiller JB Jr, Linnemeier TJ, et al. Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: Report from the Advanced Cardiovascular Systems MultiLink stent pilot study. JACC 1998;31:50-56.
21. Grégoire J, Smith D. Ragheb A, et al. Effect of stent design and configuration on collapse resistance to external circumferential pressures. (Abstract) JACC 1997;29(A):414A-415A.
22. Schrader SC, Beyar R. Evaluation of the compressive mechanical properties of endoluminal metal stents. Cathet Cardiovasc Diagn 1998;44:179-187.
23. Baier RE, Dutton RC. Initial events in interaction of blood with a foreign surface. J Biomed Mater Res 1969;3:191-206.
24. Palmaz J. New Advances in endovascular technology. Tex Heart Inst J 1997;24;156-159.
25. Isshiki T, Eto, K, Ochiai M, et al. Nininol Radius stent induces less platelet aggregation than stainless steel Palmaz-Schatz/Gianturco-Rubin II stent. JACC 1998;31( suppl A):312A.
26. Goods CM, Al-Shaibi KF, Yadav SS. et al. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation 1996;93:1803-1808.
27. Yokoi H, Nosaka H, Kimura T, et al. Influence of antiplatelet therapy (ticlopidine) on coronary stent thrombosis. (Abstract) Eur Heart J 1997;18(Abstr Suppl):621.
28. Berger PB, Bell MR, Grill DE, et al. Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin). Am J Cardiol 1998; 81:713-718.
29. Rogers C, Welt FGP, Kamovsky MJ, et al. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterio, Thromb and Vas Biol 1996; 16: 1312-1318.
30. Komowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. JACC 1998;31:224-230.
31. Gravanis MB. Vascular healing after interventional procedures: The problem of restenosis. In: King SB and Douglas JS, eds. Atlas of Heart Diseases: Interventional Cardiology. St. Louis: Mosby, 1997, pp. 1.9-1.14.
32. Yokoi H, Kimura T, Nakagawa Y, et al. Long-term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis. [Abstract] JACC 1996;27:224A.
33. Squire JC, Rogers C. Edelman ER. Stent geometry during inflation influences later restenosis. (Abstract) Circulation 1996; 94(Suppl. 1):I-259.
34. Rodgers GP, et al. The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model. Am Heart J 1991;122: 640-647.
35. Asakura M, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years. Serial angiographic and angioscopic follow-up. Circulation. 1998;97:2003-2006.
36. Serruys PW, Kutryk MJB. Handbook of coronary stents, Second Edition. London, Martin Dunitz, 1998.
37. Sievert H, Rohde S, Ensslen R, et al. Initial clinical experience with the new EBI (Bard XT) flexible coronary stent: acute results and follow-up. Cathet Cardiovasc Diagn 1998;43:159-162.
38. Grenadier E, et al. Recrossing of stents by other types of stents: clinical and angiographic report. (Abstract) JACC 1998;31 (Suppl. C):612.
39. Ormiston JA, Webster MWI, Ruygrok PN, et al. Stent distortion during simulated side-branch dilatation. (Abstract) JACC 1998;31(Suppl. A):18A.
40. Silber S, Seidel N, Muehling H, et al. In-stent restenosis using newer stent designs available in Germany. JACC 1998;31(Suppl. A):312A.
41. Yokoi H, Kimurat T, Hamasaki N, et al. Coronary stenting for Stress/Benestent equivalent lesions: Comparison of four different types of stents. JACC 1998;31(Suppl. A):313A.
42. Kobayashi Y, De Gregorio J, Reimers B, et al. Immediate and follow-up results following implantation of the Long and Short Nir stent: Comparison with the Palmaz-Schatz stent. JACC 1998;31(Suppl. A): 312A.
43. Yokoi H, Kimura T, Hamasaki N, et al. Coronary stent restenosis: Comparison of six different types of stents. JACC 1998;31(Suppl. A):313A.